baber/WOPTO huggingface dataset:
Patent AU-3437895-A (AU)
Title: Frequency offset correction
Inventor: AUVRAY GERARD
IPC: H03L7/00
Filed: 1995-10-23
Abstract: The device includes an initialisation device which initialises a control signal as a function of a reference signal. An estimation device receives a transposed signal and the control signal to produce a repetitive estimation of the frequency shift. The estimation represents the sum of the correction value and the control value greater and less than a predetermined correction threshold. The control signal is modified in response to the correction value. The transposed signal is corrected by one of the successive estimates.
Patent AU-3654493-A (AU)
Title: Absorbent pants-type diaper
Inventor: WIDLUND URBAN
IPC: A61F13/15
Filed: 1993-03-01
Abstract: A disposable, absorbent pants-type diaper includes a front-part (1), a back-part (2), a crotch-part (3) between the front and back parts (1, 2), at least two side-closure parts (12, 13) which mutually join parts of the side-edges (4, 5) of respective front and back parts, so that the pants will present a waist opening (9) and two leg openings (10, 11). The diaper pants further include an elongated absorbent pad (14), an inner casing layer (15), and an outer casing layer (16). At least one of the respective front and back parts (1, 2) has at least one elastically stretchable region (29, 30). The crotch-part (3) is essentially non-stretchable in relation to the stretchable region (29, 30). At least one of respective end-parts (17, 18) of the absorbent pad (14) is disposed within one of the elastically stretchable regions (29, 30), while the center-part (19) of the absorbent pad is disposed within the relatively non-stretchable crotch-part (3) of the pants.
Patent AU-4010300-A (AU)
Title: Direct digital frequency synthesis enabling spur elimination
Inventor: SANDER BRIAN
IPC: H03L7/08
Filed: 2000-03-16
Abstract: The invention relates to a phase lock loop, comprising :  means (DIFFERENCE ENGINE)responsive to an waveform having a frequency attribute and an input bitstream representing a desired waveform for producing an output bitstream representing a difference quantity between the analog waveform and the desired waveform;  a filter and a digital to analog converter (DAC) cooperating to produce a filtered analog difference signal;  a controlled oscillator (VCO) that produces the analog waveform; and  a first capacitor coupling the filtered analog difference signal and an input terminal of the controlled oscillator.
Patent AU-4197799-A (AU)
Title: Methods and products for inducing mucosal immunity
Inventor: MCCLUSKIE MICHAEL J
IPC: A61P37/04
Filed: 1999-05-21
Abstract: The invention relates to methods and products for inducing mucosal immunity. In particular, the invention relates to the use of immunostimulatory oligonucleotides containing a CpG motif for inducing mucosal immunity. The CpG immunostimulatory oligonucleotides may be administered alone or in combination with antigen and/or with other adjuvants.
Patent AU-4332700-A (AU)
Title: Docetaxel in combination with rhumab her2 for the treatment of cancers
Inventor: VOGEL CHARLES L
IPC: A61K38/00
Filed: 2000-04-07
Abstract: The present invention relates to a method of treating cancer, comprising administering a dose of docetaxel and a dose of rhuMAb HER2 to a patient in need thereof, wherein said dosages have a synergistic therapeutic effect when compared to the administration of docetaxel or rhuMAb HER2 alone.
Patent AU-4494700-A (AU)
Title: Mutant human cd80 and compositions for and methods of making and using the same
Inventor: SEKALY RAFICK P
IPC: C07K19/00
Filed: 2000-04-27
Abstract: Improved vaccines and methods of using the same are disclosed Immunosuppressive compositions for treating individuals who have autoimmune diseases or transplants and methods of using the same are disclosed.
Patent AU-4613293-A (AU)
Title: Condensed heterocyclic compounds, their production and use
Inventor: NATSUGARI HIDEAKI
IPC: C07D241/52
Filed: 1993-09-03
Abstract: Novel compound represented by the formula: <CHEM>  wherein ring A may be substituted;  ring B represents an optionally substituted benzene ring; either X or Y represents -NR<1>- (R<1> represents a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted hydroxyl group or an optionally substituted amino group), -O- or -S-, the other representing -CO-, -CS- or -C(R<2>)R<2a>- (R<2> and R<2a> independently represent a hydrogen atom or an optionally substituted hydrocarbon group), or either X or Y represents -N=, the other representing =CR<3>- (R<3> represents a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group , an optionally substituted amino group, a substituted hydroxyl group or a mercapto group substituted by an optionally substituted hydrocarbon group);  <........> represents a single or double bond; when <........> is a single bond, Z represents -CR<4>- (R<4> represents a hydrogen atom, hydroxyl group or an optionally substituted hydrocarbon group) or a nitrogen atom, or (ii) when <........> is a double bond, Z represents a carbon atom; D represents a C1-3 alkylene group which may be substituted by an oxo group or a thioxo group, or D and Y, taken together, may form a 5- to 7-membered ring which may be substituted by an oxo group or a thioxo group; E represents -NR<5>- (R<5> represents a hydrogen atom or an optionally substituted hydrocarbon group), -O- or -S(O)n- (n is 0,1 or 2), or R<5> and Y, taken together, may form a 5- to 7- membered ring which may be substituted by an oxo group or a thioxo group;  G represents a bond or a C1-3 alkylene group; Ar represents an optionally substituted aryl group or an optionally substituted heterocyclic group, provided that (1) when (i) -X-Y- represents - O-CO- or -CO-O-, (ii) D represents -CO- and (iii) E represents -NR<5>-, either (a) G represents a C1-3 alkylene group and Ar represents a substituted aryl group or a substituted heterocyclic group, or (b) G represents a bond and R<5> represents an optionally substituted hydrocarbon group, and (2) when -X-Y- represents -NH-CO-, D represents -CO-, or a salt thereof having an excellent activity of inhibiting ACAT, lowering chlesterol in blood and inhibiting tachykinin recepter, or a salt thereof, their production and use.
Patent AU-4740485-A (AU)
Title: Method of and device for manufacturing an optical fibre having a protective coating
Inventor: JOCHEM CORNELIS MARINUS GERRIT
IPC: C03B37/023
Filed: 1985-09-12
Abstract: 1. A method of manufacturing an optical fibre (10) having a coating of synthetic resin, in which the fibre is drawn from the end of a preform (9), which end is heated to the drawing temperature, after which the fibre is cooled, the fibre being led through a gas-filled cooling device (2) in which the fibre contacts the gas, and after the fibre has cooled it is led through a device (6) for providing the synthetic resin coating, characterized in that the fibre is cooled predominantly by heat transfer to a strongly cooled wall (2B), the gas serving as a heat-transporting medium.
Patent AU-4771290-A (AU)
Title: Polyolefin composition
IPC: C08K13/02
Filed: 1990-01-05
Abstract: Coherent thermoplastic aggregates with very high content of pulverulent mineral materials, said aggregates comprised of the said mineral materials, further of polyolefin polymers and/or copolymers, and possibly additionally of miscellaneous known additives; characterized in that, with the aim of achieving a density near to or at most equal to the theoretical density of the pulverulent mineral materials entering into their composition, while still having excellent compatibility with the polymers of redispersion, i.e., the polymers into which the subject aggregates are to be mixed, the interparticle voids between the grains of the mineral materials, which grains are basically in contact with each other, are at most filled-in the presence of a fluidifacient agent-by at least one polyolefin polymer and/or copolymer having a fusion temperature and/or softening temperature at least equal to 60 DEG  C., and having a fluidity index (ASTM 1238) of at least 50.
Patent AU-4842390-A (AU)
Title: Thermoplastic graft copolymers and their use as compatibilizers
Inventor: CHUNG TZE-CHIANG
IPC: C08F255/00
Filed: 1989-11-20
Abstract: Graft copolymers are disclosed having formula (I), wherein R and R' are hydrogen, alkyl, and the primary and secondary alkyl halides, a ranges from about 14 to 70,000, b ranges from 0 to about 70,000, c ranges from 0 to about 70,000, d ranges from about 1 to 70,000, X comprises a halogen, and Nu is a nucleophilic residue provided by a thermoplastic polymeric nucleophile having a molecular weight of at least about 1,000 and being sufficiently nucleophilic such that said nucleophile is capable of donating electrons to benzyl halides. Methods for compatibilizing polymer blends utilizing such graft copolymers are also disclosed.
Patent AU-4863797-A (AU)
Title: Use of glp-1 peptides
Inventor: KNUDSEN LISELOTTE BJERRE
IPC: A61K38/26
Filed: 1997-11-07
Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
Patent AU-4940293-A (AU)
Title: N-(hydroxyethyl)butanediamide derivatives as renin inhibitors
Inventor: ANDERSON PAUL CATES
IPC: A61K31/4406
Filed: 1993-09-15
Abstract: Disclosed herein are compounds of the formula:    A-N(R<1>)C(O)CH2CHR<2>C(O)-B   wherein A is an oxygen-bearing radical selected from the group consisting of: (a) HO-CH(R<3>)CH2 wherein R<3> is, for example, hydrogen, lower alkyl, lower cycloalkyl, phenyl or an unsubstituted five- or six-membered heterocyclic ring containing one or two heteroatoms selected from the group of N, O or S; (b) HO-CH2CH(R<4>) wherein R<4> is, for example, lower alkyl or phenyl(lower)alkyl; and (c) HO-CR<5>(R<6>)CH2 wherein each of R<5> and R<6> is lower alkyl; or R<5> and R<6> together with the carbon atom to which they are attached form a 1,1-(lower cycloalkanediyl), 1,1-(4-hydroxycyclohexanediyl) or 1,1-(4-oxocyclohexanediyl); (d) (lower alkoxy)CR<5A)<R<6A>)CH2 wherein each of R<5A> and R<6A> is lower alkyl; or R<5A> and R<6A> together with the carbon atom to which they are attached form a 1,1-(lower cycloalkanediyl); and (e) (lower alkyl)C(O)CH2; R<1> is, for example, benzyl, alkyl, a substituted alkyl such as cyclohexylmethyl, or R<7>R<8>NC(O)CH2 wherein R<7> and R<8> are alkyl such as methyl or ethyl; R<2> is, for example, alkyl, cycloalkylmethyl, 1H-imidazol-4-ylmethyl, 4-thiazolylmethyl or (2-amino-4-thiazolyl)methyl; and B is a renin substrate transition state mimic, for example, [1(S)-(cyclohexylmethyl)-2(R),3(S)-dihydroxy-5-methylhexyl]amino. The compounds inhibit renin activity and are indicated for the treatment of hypertension and congestive heart failure.
Patent AU-5061493-A (AU)
Title: Filling machine
Inventor: WADELL LARS GUSTAF ALBERT
IPC: B65G65/48
Filed: 1993-11-10
Abstract: A machine and process for filling a product (13) volumetrically which comprises introducing the product into a hopper (12), recording the level of the product (13) in the hopper (12) and transmitting the recorded information to a computer (18), conveying an empty chamber (19) to a position beneath the hopper (12), automatically adjusting the volume of the empty chamber (19) and filling the empty chamber (19) with the product (13) conveying the filling chamber (19) away from the hopper (12) and discharging the product (13), recording the weight of the discharged product (13) and transmitting the recorded weight to the computer (18), the automatic adjustment of the volume of the empty chamber (19) being based on the recorded imformation transmitted to the computer (18). <IMAGE>
Patent AU-5082090-A (AU)
Title: Immunogenic compositions against gastrin peptides
Inventor: GEVAS PHILIP C
IPC: C07K19/00
Filed: 1990-01-23
Abstract: Immunogenic compositions useful for the treatment of ulcers or tumors whose growth is dependent on or stimulated by gastrin hormones are disclosed. The immunogenic compositions induce antibodies in a subject which selectively neutralize the specific hormones. Pharmaceutical compositions comprising effective amounts of the immunogenic compositions and methods of treatment using the compositions are disclosed. A method of reversing the inventive treatments by neutralizing the antibodies induced in vivo is also disclosed.
Patent AU-5202298-A (AU)
Title: Medical fluid injector
Inventor: BATTIATO DANE J
IPC: A61M5/145
Filed: 1997-11-18
Abstract: A medical fluid injector includes: an air detection system for detecting air in the neck of the syringe; a hand-operated control lever for controlling movement of the injector ram; magnetic conductors for delivering magnetic fields from a power head face plate to an internal circuit board to permit detection of different face plates; a tilt sensor detecting the tilt angle of the power head to control the speed of motion brought about by the hand-operated control lever and to control an invertible display; and a monitor microcontroller for monitoring the behavior of the central processing unit to detect and react to error conditions.
Patent AU-5326900-A (AU)
Title: Method and system for master to master communication in control systems
Inventor: BARBER RONALD W
IPC: H04L29/06
Filed: 2000-06-07
Abstract: A master controller (28) in a control area network system in a larger control area network (16, 18) may have a plurality of devices (33) coupled thereto. The devices generate data which the master controller directs to a destination device coupled to the same master controller, a different master controller in the same control area network or to a different master controller in a different control area network. The master controller directs the data using a connections table acquired from one or more other master controllers to which the master controller may communicate with.
Patent AU-5377301-A (AU)
Title: Production tool process
Inventor: SWEI GWO SHIN
IPC: B24D3/00
Filed: 2001-04-24
Abstract: The production of an engineered surface on a coated abrasive is made more versatile by the use of a production tool obtained using a master tool created by a rapid prototyping technique.
Patent AU-5438299-A (AU)
Title: Pyrimidine compounds
Inventor: BREAULT GLORIA ANNE
IPC: A61P9/00
Filed: 1999-08-24
Abstract: A pyrimidine derivative of formula (I) wherein, for example, R<SUP>1 </SUP>is hydrogen, (1-6C)alkyl, (3-5C)alkenyl or (3-5C)alkynyl; Q<SUB>1 </SUB>and Q<SUB>2 </SUB>are independently selected from phenyl, naphthyl, indanyl and 1,2,3,4-tetrahydronaphthyl; and one or both of Q<SUB>1 </SUB>and Q<SUB>2 </SUB>bears on any available carbon atom one substituent of formula (Ia) [provided that when present in Q<SUB>1 </SUB>the substituent of formula (Ia) is not adjacent to the -NH- link]; wherein, for example, X is CH<SUB>2</SUB>, O, S or NH; Y is H or as defined for Z; Z is OH, SH, NH<SUB>2</SUB>, (1-4C)alkoxy, (1-4C)alkylthio, -NH(1-4C)alkyl, -N[(1-4C)alkyl]<SUB>2 </SUB>or -NH-(3-8C)cycloalkyl; n is 1, 2 or 3; m is 1, 2 or 3; and Q<SUB>1 </SUB>and Q<SUB>2 </SUB>may optionally bear other substituents selected, for example, from halogeno, (1-6C)alkyl, cyano and (2-4C)alkenyl; or a pharmaceutically-acceptable salt or in-vivo-hydrolysable ester thereof; are useful as anti-cancer agents; and processes for heir manufacture and pharmaceutical compositions containing them are described.
Patent AU-5467186-A (AU)
Title: 1,3-dioxolan and 1,4-dioxan derivatives
Inventor: HUBSCHWERLEN CHRISTIAN NICOLAS
IPC: C07D403/04
Filed: 1986-03-12
Abstract: There is presented optically uniform  beta -lactams of the formulae <IMAGE>   wherein Z is a readily cleavable acyl group, R1 is amino or a group convertible into amino, R2 is hydrogen or a readily cleavable protecting group and R3 and R4 each are a lower hydrocarbon group which optionally contains oxygen and which is attached via a carbon atom, whereby these groups can also be joined with one another to form a ring, with the proviso that R1 is a readily cleavable acylamino when R2 is hydrogen, and the corresponding optical antipodes, their manufacture and use in the manufacture of antimicrobially-active  beta -lactams as well as novel intermediates usable in their manufacture.
Patent AU-5482396-A (AU)
Title: Method of treating cardiac arrest
Inventor: MANNING JAMES E
IPC: A61M60/833
Filed: 1996-04-12
Abstract: A method of treating a subject under cardiac arrest comprises the steps of: blocking the descending aorta of the subject; then withdrawing blood from the subject; oxygenating the blood withdrawn from the subject; and perfusing the aortic arch of the subject with oxygenated blood in an amount effective to deliver oxygen to the heart of the subject. This method enables the subject to continue to receive oxygenating material (i.e., blood in this instance) without the danger of volume overload that would be present if another oxygenated solution were continuously infused.
Patent AU-5754499-A (AU)
Title: Die cutting machine
Inventor: RIGLIETTI ANTONIO
IPC: B26F1/44
Filed: 1999-09-28
Abstract: Automatic die cutting machine for making laminar labels, comprising a supporting frame (2), supporting a substantially horizontal surface plate (3), means for feeding a film (F) of laminar material step by step along a longitudinal direction (L), means comprising a pair of independent punches (8, 8') with blades (10, 10') reproducing the shape of the label to shear said film (F) forming one or more labels (T) at a time, staging means (9, 9') for the cut labels (T), and grasping means for removal and transfer of the cut labels (T) incorporated in the cutting means (8, 8'). Every punch (8, 8') includes elastic compensation means adapted to maintain the blades (10, 10') substantially parallel to the surface plate (3) and constantly in the predetermined tolerances.
Patent AU-5881590-A (AU)
Title: Novel heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same
Inventor: NADOR KAROLY
IPC: C07D279/06
Filed: 1990-07-10
Abstract: The invention relates to nitrogen- and sulfur-containing heterocyclic compounds of the formula (I), <CHEM>  wherein Ar      represents an optionally mono- or polysubstituted aryl or heteroaryl group;  R<1>      represents a carbonyl or (C2-6alkenyl)-carbonyl group; R<2>      represents a hydrogen atom, or a C1-6alkyl, phenyl or phenyl(C1-4alkyl) group; R<3>      represents a hydrogen atom or a (C1-6 alkoxy)carbonyl group; R<4> and R<5>,      which may be the same or different, represent a hydrogen atom or a C1-6alkyl group; R<6>      represents a hydrogen atom or a C1-6alkyl group or halophenyl group;  m      is 0 or 1; and  n is 1 or 2, with the proviso that R<2> is a hydrogen atom when m is 0, and acid addition salts of the compounds of formula (I) and pharmaceutical compositions thereof. The invention also relates to processes for the preparation of these compounds. The compounds of formula (I) show a significant cerebral antihypoxic activity.
Patent AU-6017696-A (AU)
Title: Processed ginseng having enhanced pharmacological effect
Inventor: PARK MAN KI
IPC: A61P3/08
Filed: 1996-06-05
Abstract: The present invention relates to a processed ginseng having an enhanced pharmacological effect by heating ginseng at a high temperature. More specifically, the present invention relates to a processed ginseng produced by heating ginseng for 0.5 to 20 hours at 120 to 180  DEG C, of which the ratio of ginsenoside (Rg3+Rg5)/(Rc+Rd+Rb1+Rb2) is above 1.0 and thus exhibits an enhanced pharmacological activity, and to a beverage composition comprising said processed ginseng. The processed ginseng heat-treated according to the present invention provides an enhanced pharmacological effect since it contains greatly increased amount of the existing pharmacologically active components as well as newly formed pharmacologically active components in comparison with white ginseng, fresh ginseng and the like which are utilized until now.
Patent AU-6125296-A (AU)
Title: Oligonucleotides specific for hepatitis b virus
Inventor: CRAIG CHARLES J
IPC: C12N15/113
Filed: 1996-06-04
Abstract: The present invention discloses synthetic oligonucleotides complementary to contiguous and noncontiguous regions of the HBV RNA. Also disclosed are methods and kits for inhibiting the replication and expression of HBV, and for treating HBV infections and associated conditions.
Patent AU-6163186-A (AU)
Title: Bacteria for expressing a polysaccharide depolymerase containing a novel recombinant plasmid
Inventor: VANDENBERGH PETER A
IPC: C12N15/63
Filed: 1986-08-20
Abstract: A segment of a bacteriophage encoding for a polysaccharide depolymerase which has been cloned and expressed in Escherichia coli is described. In particular, bacteriophage ERA103 was found to consist of five EcoRI fragments labeled: A, 7.5-kb; B, 5.0-kb; C, 2.7-kb; D, 2.1-kb and E, 1.8-kb. Fragment B encodes for the depolymerase and was cloned into the positive-selection vector pOP203(A2+), pBR322 and the expression vector pKK223-3. The depolymerase is applied to rosaceous plants to prevent Fireblight caused by Erwinia amylovora by depolymerizing a polysaccharide produced by this bacteria.
Patent AU-6191694-A (AU)
Title: Process for preparing organic carbamates
IPC: C07C269/04
Filed: 1994-05-05
Abstract: A process has been found for the preparation of organic carbamates from a basic amine, carbon dioxide and an alkylating agent, the process being characterised in that the amine is first reacted with carbon dioxide in the presence of one or more basic compounds of the elements lithium, sodium, magnesium, potassium, rubidium, strontium, caesium, barium and/or ammonium, and subsequently adding the alkylating agent.
Patent AU-6193190-A (AU)
Title: Draw-roller unit for a web-fed printing machine
Inventor: GERMANN ALBRECHT JOSEF
IPC: B41F11/02
Filed: 1990-08-28
Abstract: The pull roller unit has only one suction roller (20b, 21b) as pull roller, in which a permanently acting suction effect acts along that circumferential section which is wrapped by the paper web whereas the remaining circumferential section is not subjected to any suction effect. The suction roller has a fixed, hollow roller core (65) and a roller shell (61) which can be rotated about said core and is made of carbon fibres impregnated with plastic with suction openings (62) distributed over its circumference. The roller core (65) is provided on one side with an axial nozzle (68b) for attachment to the machine frame and for connection to a source of negative pressure, on its other side with a bearing journal (66), and on its circumference exhibiting passage openings (70) with two radial partitions (69) which are arranged with a certain angular spacing from one another and enclose a suction chamber between them. The roller shell is mounted on the bearing journal (66) by a conical connection flange (61b), which is attached directly to the armature shaft of the drive motor, and on the nozzle (68b) by its other end, the gap between the roller shell and the partitions (69) being almost airtight. Instead of a suction roller, a pull roller can also be provided which is subjected to compressed air on the outside along the circumferential section mentioned, or the suction air and compressed air effect can be combined. 
<IMAGE>
Patent AU-6311796-A (AU)
Title: Matrix metalloproteinase inhibitors
Inventor: HUXLEY PHILIP
IPC: C07C259/06
Filed: 1996-07-01
Abstract: Compounds of formula (I), wherein R2 represents a group R6-A- wherein A represents a divalent straight or branched, saturated or unsaturated hydrocarbon chain of up to 12 C atoms and R6 represents hydrogen or an optionally substituted aryl, heterocyclyl, cycloalkyl or cycloalkenyl group; and R4 and R5 each independently represents hydrogen, a C1-C4 alkyl group, or an aryl(C1-C4 alkyl) group, have matrix metalloproteinase inhibitory activity.